Lilly Foundation Boosts BioCrossroads

BioCrossroads CEO David Johnson says the grant comes at a "pivotal point in the advancement of the state's life sciences industry."

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Indiana’s life sciences initiative has been awarded a two-year, $2.9 million grant from Lilly Endowment Inc. BioCrossroads says the funding will support its ongoing charitable, educational and scientific efforts.

BioCrossroads Chief Executive Officer David Johnson says the grant comes at a "pivotal point in the advancement of the state’s life sciences industry." The funding will go to the Central Indiana Corporate Partnership Foundation.

The organization says, to date, it has raised more than $377 million in grant money. CICP and BioCrossroads say the funding has supported major projects including the establishment of the Indiana Health Information Exchange, the Indiana I-STEM Network and the Datalys Center for Sports Injury Research. It has also boosted the state’s orthopedic initiative OrthoWorx and agriculture innovation initiative AgriNovus Indiana.